Identification of a synthetic peptide that mimics an HIV glycoprotein 120 envelope conformational determinant exposed following ligation of glycoprotein 120 by CD4

AIDS Research and Human Retroviruses

Volumn 13, Issue 8, 1997, Pages 657-664

  Weinberg, Jason ^a   Liao, Hua Xin ^a   Torres, Jose V ^b   Matthews, Thomas J ^a   Robinson, James ^c   Haynes, Barton F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; EPITOPE; GLYCOPROTEIN GP 120; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; SYNTHETIC PEPTIDE; VIRUS ENVELOPE PROTEIN;

ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS ENVELOPE;

EID: 0030915340     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.657     Document Type: Article

References (22)

1. Lasky LA, Nakamura G, Smith DH, Fennie C, Shimasaki C, Patzer E, Berman P, Gregory T, and Capon DJ: Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 1987;50: 975-985.
2. Dowbenko D, Nakamura G, Fennie C, Shimasaki C, Riddle L, Harris R, Gregory T, and Lasky L: Epitope mapping of the human immunodeficiency virus type 1 gp120 with monoclonal antibodies. J Virol 1988;62(12):4703-4711.
3. Palker TJ, Clark ME, Langlois AJ, Matthews TJ, Weinhold KJ, Randall RR, and Bolognesi DP: Type-specific neutralisation of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc Natl Acad Sci (USA) 1988;85:1932-1936.
4. Rusche JR, Javaherian K, McDanal C, Petro J, Lynn DL, Grimailia R, Langlois A, Gallo RC, Arthur LO, Fischinger P, Bolognesi DP, Putney SD, and Matthews TJ: Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope gp120. Proc Natl Acad Sci (USA) 1988;85:3198-3193.
5. Nara PL, Garrity RR, and Goudsmit J: Neutralization of HIV-1: A paradox of humoral proportions. FASEB J 1991;5:2437-2455.
6. Sattentau QJ: CD4 activation of HIV fusion. Int J Cell Cloning 1992;10:323-332.
7. Sattentau QJ and Moore JP: Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J Exp Med 1991;174:407-415.
8. McKeating JA, Moore JP, Ferguson M, Marsden HS, Graham S, Almond JW, Evans DJ, and Weiss RA: Monoclonal antibodies to the C4 region of human immunodeficiency virus type 1 gp120: Use in topological analysis of a CD4 binding site. AIDS Res Hum Retroviruses 1992;8(4):451-459.
9. Nakamura GR, Byrn R, Wilkes DM, Fox JA, Hobbs MR, Hastings R, Wessling HC, Norcross MA, Fendly BM, and Berman PW: Strain specificity and binding affinity requirements of neutralizing monoclonal antibodies to the C4 domain of gp120 from human immunodeficiency virus type 1. J Virol 1993;67(10):6179-6191.
10. Wyatt R, Thali M, Tilley S, Pinter A, Posner M, Ho D, Robinson J, and Sodroski J: Relationship of the human immunodeficiency virus type 1 gp120 third variable loop to a component of the CD4 binding site in the fourth conserved region. J Virol 1992;66(12): 6997-7004.
11. Burkley L, Mulrey N, Blumenthal R, and Dimitrov DS: Synergistic inhibition of human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion and infection by an antibody to CD4 domain 2 in combination with anti-gp120 antibodies. J Virol 1995;69(7):4267-4273.
12. Clavel F and Chameau P: Fusion from without directed by human immunodeficiency virus particles. J Virol 1994;68(2):1179-1185.
13. Moore JP, Thali M, Jameson BA, Vignaux F, Lewis GK, Poon S, Charles M, Fung MS, Sun B, Durda PJ, Akerblom L, Wahren B, Ho DD, Sattentau QJ, and Sodroski J: Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: Probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop. J Virol 1993; 67(8):4785-4796.
14. Thali M, Moore JP, Furman C, Charles M, Ho DD, Robinson J, and Sodroski J: Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J Virol 1993;67(7):3978-3988.
15. Myers G, Berzofsky JA, Korber B, Smith RF, and Pavlakis GN (eds.): Human Retroviruses and AIDS. Theoretical Biology and Biophysics Group, Los Alamos, New Mexico, 1991, pp. II-79-80 and III-6-8A.
16. Haynes BF, Torres JV, Langlois AJ, Bolognesi DP, Gardner MB, Palker TJ, Scearce RM, Jones DM, Moody MA, McDanal C, et al.: Induction of HIVMN neutralizing antibodies in primates using a prime-boost regimen of hybrid synthetic gp120 envelope peptides. J Immunol 1993;151(3):1646-1653.
17. Hart MK, Palker TJ, Matthews TJ, Langlois AJ, Lerche NW, Martin ME, Scearce RM, McDanal C, Bolognesi DP, and Haynes BF: Synthetic peptides containing T and B cell epitopes from human immunodeficiency virus envelope gp120 induce anti-HIV proliferative responses and high titers of neutralizing antibodies in rhesus monkeys. J Immunol 1990;145(8):2677-2685.
18. Vu HM, deLorimier R, Moody MA, Haynes BF, and Spicer L. Comparison of NMR-derived solution conformations and functional activities of two immunogenic peptides taken from the C4-V3 domains of gp120 envelope proteins of HIV-1 strains Can0A and RF. J Biochem 1996;35(16):5158-5165.
19. Wyatt R, Moore J, Accola M, Desjardin E, Robinson J, and Sodroski J: Involvement of the V1/V2 loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. J Virol 1995;69:5723-5733.
20. D'Souza MP, Milman G, Bradac JA, McPhee D, Hanson CV, Hendry RM, and Collaborating Investigators: Neutralization of primary HIV-1 isolates by anti-envelope monoclonal antibodies. AIDS 1995;9:867-874.
21. Moore JP, McCutchan FE, Poon S, Mascola J, Liu J, Cao Y, and Ho DD: Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies. J Virol 1994;68(12):8350-8364.
22. Feng Y, Brocter CC, Kennedy PE, and Berger EA: HIV-1 entry co-factor: Functional cDNA cloning of a seven-transmembrane, G-protein-coupled receptor. Science 1996;272:872-877.